COVID vaccine update: FDA authorizes Pfizer booster for some children under age five
Fox News
The U.S. Food and Drug Administration (FDA) has authorized a single booster dose of the Pfizer-BioNTech COVID-19 Vaccine, Bivalent for children 6 months through 4 years of age.
Children in that age range who only received the first two doses of the Pfizer COVID-19 vaccine are not currently eligible for this booster. The FDA recommends that they complete the three-dose series. "Just because a vaccine is approved doesn’t mean it should automatically be used." Melissa Rudy is health editor and a member of the lifestyle team at Fox News Digital.
The FDA said in its announcement that the Pfizer-BioNTech COVID-19 Vaccine, Bivalent includes an mRNA component that provides a "broadly protective" immune response against COVID-19, as well as against the omicron variants BA.4 and BA.5.